Traditional ducted fume hoods remain the gold standard for chemical containment in most laboratories, but several innovative alternatives can provide effective protection while offering unique advantages. These alternatives include glove boxes, snorkel systems, and specialized containment units that address specific laboratory needs while potentially reducing energy consumption and installation complexity.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Organomation_Alternatives_to_Traditional_Fume_Hoods_A_Comprehensive_Guide_to_Laboratory_Containment_Solutions_9c39f814df.jpg" alt="Organomation: Alternatives to Traditional Fume Hoods: A Comprehensive Guide to Laboratory Containment Solutions" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Organomation_Alternatives_to_Traditional_Fume_Hoods_A_Comprehensive_Guide_to_Laboratory_Containment_Solutions_9c39f814df.jpg 208w," sizes="100vw" width="2016" height="1512"><h3>Glove Boxes: Maximum Containment for High-Risk Materials</h3>Glove boxes, also known as isolation enclosures, represent the highest level of containment available for laboratory operations. These fully enclosed systems create a complete physical barrier between operators and hazardous materials while maintaining precise environmental control.<h4>Key Features and Applications</h4>Glove boxes consist of hermetically sealed stainless steel or transparent enclosures equipped with integrated gloves that allow manipulation without breaking containment. Modern systems include sophisticated transfer airlocks, sensors, regulators, and automatic safety flow systems that compensate for pressure drops or accidental containment breaches.These systems excel in applications requiring extremely low occupational exposure limits (OELs). For materials classified as OEB 4 (1-50 μg/m³) or OEB 5 (&lt;1 μg/m³), glove boxes provide containment levels as low as 0.1 μg/m³ or even 0.01 μg/m³. This makes them essential for handling highly potent pharmaceutical compounds, radioactive materials, and other extremely hazardous substances.<h4>Specialized Configurations</h4>The versatility of glove box technology extends to numerous specialized applications. Compounding Aseptic Isolators (CAI) create positive pressure environments for sterile pharmaceutical compounding, meeting USP 797 requirements. Conversely, Compounding Aseptic Containment Isolators (CACI) operate under negative pressure for handling hazardous drugs per USP 800 guidelines.Inert atmosphere glove boxes utilize nitrogen or argon purging to create oxygen-free environments essential for moisture-sensitive materials and anaerobic research. These systems feature automated purge cycles and one-touch operation for seamless anaerobic transitions.<h4>Construction Materials and Performance</h4>Stainless steel construction (316L grade) provides optimal chemical resistance and durability, with continuous seam welds and wide radius corners facilitating easy decontamination. Leak rates typically specification below 0.05% chamber volume per hour, verified through pressure decay testing. Advanced systems incorporate built-in sterilization capabilities using vaporized hydrogen peroxide (VHP) generators for thorough decontamination between uses.<h4>Advantages and Limitations</h4>Glove boxes offer unparalleled containment performance with complete environmental isolation, precise atmospheric control, and robust decontamination capabilities. The closed design eliminates airflow disturbances that can compromise containment in open-front systems.However, glove boxes require larger footprints, higher initial investment, and more complex maintenance compared to open containment systems. The enclosed design may limit accessibility for larger equipment or rapid material transfers, and extended use can cause operator fatigue due to the ergonomic constraints of glove manipulation.<h3>Snorkel Systems: Localized Fume Extraction</h3>Snorkel systems, also known as articulating extraction arms or fume extraction arms, provide targeted fume capture at the source while maintaining workspace flexibility.<h4>Design and Operation</h4>These systems feature flexible, articulating arms typically 3-8 inches in diameter with working radii ranging from 3-14 feet. The arms incorporate three adjustable joints allowing 360-degree rotation and positioning flexibility. Standard configurations handle airflow rates from 30-1000 CFM depending on arm diameter and application requirements.Multiple specialized configurations address specific laboratory needs. The Original model provides general-purpose fume extraction for standard laboratory applications. ESD/EX models incorporate conductive materials to eliminate electrostatic discharge risks in electronic environments. CHEM models feature double anodized aluminum construction for enhanced corrosion resistance in aggressive chemical environments.<h4>Installation and Integration</h4>Snorkel systems mount to walls, ceilings, workbenches, or specialized support structures. They integrate with facility HVAC systems or standalone filtration units depending on application requirements. Mobile configurations with integrated collectors provide complete portability for applications requiring frequent repositioning.Advanced mounting systems include swing boom configurations for extended reach applications (18-35 feet) and rail-mounted trolley systems for linear positioning along extended work areas. These systems require minimal operator force for positioning and repositioning.<h4>Hood Options and Customization</h4>Extraction hoods vary based on application requirements. Transparent dome hoods optimize visibility for precision work while providing effective capture for high-dispersion particles. Metal hoods offer enhanced durability and chemical resistance for aggressive environments. Specialized hood geometries optimize capture efficiency for specific processes like chromatography or analytical instrumentation.<h4>Performance and Applications</h4>Snorkel systems excel in applications requiring localized fume extraction from specific equipment like chromatographs, analytical instruments, or small-scale chemical processes. They provide effective capture distances of 12-20 inches from the source with capture areas up to 20 inches in diameter.These systems prove particularly valuable in laboratories with limited space, flexible furniture arrangements, or applications where full fume hood installation is impractical. Educational laboratories benefit from their overhead mounting that preserves floor space while providing necessary ventilation.<h4>Energy Efficiency Considerations</h4>Snorkel systems typically require lower airflow rates than full-sized fume hoods, reducing energy consumption and HVAC demands. When integrated with variable speed controls and demand-based operation, they provide energy-efficient alternatives to constant-volume hood operation.<h3>Ductless Fume Hoods: Energy-Efficient Alternatives</h3>Ductless fume hoods represent a growing alternative to traditional ducted systems, offering significant energy savings and installation flexibility while maintaining safety standards.<h4>Energy Performance Advantages</h4>Ductless systems achieve remarkable energy efficiency improvements over traditional ducted hoods. Studies indicate energy efficiency improvements of 18-25 times compared to total exhaust systems, primarily through air recirculation rather than continuous exhaust of conditioned air. This translates to substantial reductions in HVAC loads and operational costs.A comparative analysis of a hypothetical 30-hood facility demonstrated that ductless systems consume only 2.4 kBTU per square foot annually compared to 127.5 kBTU for constant volume hoods and 74.1 kBTU for VAV systems. Carbon dioxide emissions similarly decrease from 873 tons annually for constant volume systems to just 55 tons for ductless alternatives.<h4>Filtration Technology and Safety</h4>Modern ductless hoods employ sophisticated multi-stage filtration systems combining carbon, HEPA, and specialized chemical filters. Advanced monitoring systems continuously assess filter performance and provide alerts when replacement is required. These systems maintain face velocities of 100 feet per minute, meeting OSHA recommendations while achieving ASHRAE 110 certification standards.Filter replacement costs range from $350-2,000 annually, representing significant savings compared to ongoing HVAC operational costs of ducted systems. Filter life varies based on application but typically extends 6-12 months under normal laboratory conditions.<h4>Installation and Flexibility Benefits</h4>Ductless hoods arrive fully certified and ready for immediate use without requiring building modifications or HVAC integration. This eliminates lengthy installation timelines and coordination requirements associated with ducted systems. Mobile configurations provide additional flexibility for laboratories requiring equipment relocation.The plug-and-play nature of ductless systems allows rapid deployment and adaptation to changing laboratory needs without facility downtime or infrastructure modifications.<h4>Application Limitations and Considerations</h4>Ductless systems prove most effective for applications involving naturally evaporating chemicals in limited volumes. They are not suitable for heated chemicals, highly volatile solvents, or applications generating large volumes of hazardous vapors. Regular filter monitoring and replacement are essential to maintain protection effectiveness.<h3>Specialized Containment Solutions</h3>Beyond traditional glove boxes and snorkel systems, several specialized containment solutions address specific laboratory needs.<h4>Downflow Booths</h4>Downflow booths utilize unidirectional airflow to carry contaminants away from operator breathing zones into low-level exhaust systems. These systems prove effective for powder handling operations requiring containment levels of 50-100 μg/m³.Recirculatory configurations suit powder operations while single-pass designs handle applications involving solvents or vapor generation. HEPA filtration and controlled airflow patterns (typically 90 FPM) provide effective containment while maintaining operator accessibility.<h4>Mobile Fume Extractors</h4>Portable fume extraction units combine the benefits of source capture with complete mobility. These self-contained systems feature integrated filtration, typically 3-stage systems with aluminum mesh pre-filters, MERV 15 cartridge filters, and activated carbon after-filters.Units range from 750-1200 CFM capacity with 6-8 inch diameter extraction arms in lengths from 7-14 feet. Advanced models incorporate pulse-cleaning systems extending filter life 6-7 times beyond traditional reverse-pulse systems.<h4>Biosafety Cabinets and Biological Containment</h4>While primarily designed for biological applications, Class III biosafety cabinets function as glove box systems for maximum biological containment. These systems provide complete enclosure with HEPA filtration for handling BSL-3 and BSL-4 materials.Class II biosafety cabinets offer open-front operation with HEPA filtration for lower-risk biological materials while providing some chemical containment capabilities for limited applications.<h3>Selection Criteria and Implementation Considerations</h3><h4>Material Hazard Assessment</h4>The selection of appropriate fume hood alternatives depends primarily on the occupational exposure limits and toxicological properties of materials being handled. OEB classifications provide guidance for containment requirements:<ul><li>OEB 1-2 (100-5000 μg/m³): Standard downflow booths with minimal additional controls</li><li>OEB 3 (10-100 μg/m³): Enhanced downflow booths or limited containment systems</li><li>OEB 4 (1-10 μg/m³): Specialized containment or glove box systems recommended</li><li>OEB 5 (&lt;1 μg/m³): Full isolation systems required</li></ul><h4>Economic Considerations</h4>Initial investment costs vary significantly among alternatives. Ductless hoods typically require lower upfront investment due to eliminated infrastructure requirements. Glove boxes represent higher initial costs but provide superior long-term containment assurance for high-risk materials.Operational costs favor ductless systems through reduced energy consumption, while glove boxes may require higher maintenance but offer lower risk exposure costs.<h4>Laboratory Design Integration</h4>Space constraints and laboratory layout significantly influence alternative selection. Snorkel systems optimize overhead space utilization while maintaining floor accessibility. Ductless hoods provide location flexibility without ducting constraints. Glove boxes require dedicated space but offer maximum containment assurance.Future laboratory needs and potential application changes should inform selection decisions, with modular and mobile solutions providing greater adaptability.The landscape of fume hood alternatives continues expanding with advancing filtration technology, improved energy efficiency, and enhanced safety monitoring systems. Each alternative offers distinct advantages addressing specific laboratory requirements while potentially providing economic and operational benefits over traditional ducted systems. Proper selection requires careful assessment of material hazards, operational requirements, and facility constraints to ensure both safety and efficiency objectives are met.

Alternatives to Traditional Fume Hoods: A Comprehensive Guide to Laboratory Containment Solutions

The research group of associate professor Bob Pirok at the University of Amsterdam’s Van ’t Hoff Institute for Molecular Sciences (HIMS) is partnering with Agilent Technologies to develop advanced analytical methodologies for polymer characterisation. As part of the collaboration, the scientific instruments company has provided state-of-the-art analytical equipment that has been integrated into the self-driving analytical AI laboratory at HIMS.As modern polymers become increasingly complex in their molecular architecture and functionality, the demand for more powerful and comprehensive analytical approaches, such as two-dimensional liquid chromatography coupled to mass spectrometry (2D-LC-MS), has never been greater.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/HIMS_The_collaborative_team_in_the_HIMS_self_driving_analytical_lab_5ee413fe5e.jpg" alt="HIMS: he collaborative team in the HIMS self-driving analytical lab. From left to right: Danny van Oevelen (Agilent), Herman Breukink (Agilent), Bob Pirok (UvA), Tijmen Bos (UvA), Gerben van Henten (UvA), Michael Rodammer (Agilent) &amp; Carola Damen (Agilent)" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_HIMS_The_collaborative_team_in_the_HIMS_self_driving_analytical_lab_5ee413fe5e.jpg 208w," sizes="100vw" width="700" height="527">To advance the field of polymer analysis, the research group of Bob Pirok combines fundamental insights in separation science with automation and machine learning approaches to accelerate method development and improve polymer and materials analysis. In doing so, the group builds upon the strong foundation established by the former Polymer Analysis Group led by Prof. Peter Schoenmakers.Pirok’s research is in many cases carried out in collaboration with industrial partners. An example is the STREAMLINED consortium led by Pirok and his HIMS colleague Dr Alina Astefanei, developing analytical tools to investigate nanoplastics. It includes researchers at the Vrije Universiteit Amsterdam and various polymer companies and instrument manufacturers.<h4>Self-driving laboratory</h4>In a new partnership, the Pirok group has now joined forces with scientific instrument company Agilent Technologies. The aim is to develop and evaluate advanced workflows that meet current and emerging challenges in polymer and materials characterisationAs part of the collaboration, an <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library?mainauthorItems=10&amp;search=Revident+LC%2FQ-TOF">Agilent Revident LC/Q-TOF system</a> has been installed in the HIMS self-driving analytical AI laboratory. “There, we design AI strategies that directly interact with analytical instrumentation to optimise 1D and 2D-LC-MS methods autonomously,” Pirok explains. “This project allows us to combine state-of-the-art instrumentation with cutting-edge AI so that we can explore new solutions to complex questions in polymer analysis.”<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/HIMS_A_liquid_chromatography_system_operates_autonomously_in_the_development_of_a_method_for_analysis_of_an_industrial_sample_ac32a2000f.jpg" alt="HIMS: A liquid chromatography system operates autonomously in the development of a method for analysis of an industrial sample. In the project, Bob Pirok and Tijmen Bos will explore synergies between cutting-edge AI developments and advanced LC–MS technologies to deliver improved solutions for polymer characterization." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_HIMS_A_liquid_chromatography_system_operates_autonomously_in_the_development_of_a_method_for_analysis_of_an_industrial_sample_ac32a2000f.jpg 208w," sizes="100vw" width="700" height="524">The new instrument is a welcome addition to the group’s <a target="_blank" rel="noopener noreferrer" href="https://cast-amsterdam.org/automated-method-development/">AutoLC </a>self-driving laboratory, an autonomous method-development platform for which Pirok received the <a target="_blank" rel="noopener noreferrer" href="https://hims.uva.nl/content/news/2024/06/bob-pirok-wins-2024-htc-innovation-award.html">HTC Innovation Award</a>. It also fits in the research line of Dr Tijmen Bos, who designs data-analysis workflows specifically for polymers and has published solutions for several parties from industry. A recent example was the <a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.macromol.5c00297">characterisation of the block-length distribution of copolymers</a> using machine learning.

Advanced equipment for self-driving analytical AI laboratory

Join us in this fascinating episode of Concentrating on Chromatography as Dr. Rachael Guenter, PhD, shares her eight-year journey researching neuroendocrine tumors. Discover how her background in plant pathology and engineering shaped her translational medicine approach, and learn about the crucial role of mass spectrometry in uncovering protein-level insights in these rare cancers.&nbsp;Dr. Guenter also discusses the challenges of translating lab discoveries into clinical trials, the promise of spatial mass spectrometry for tumor heterogeneity, and the importance of collaboration between scientists, clinicians, and patients. Whether you're interested in cancer biology, mass spec applications, or cutting-edge cancer research, this episode delivers valuable perspectives and inspiring advice from a leading expert in the field. &nbsp;<h3>Video Transcription</h3>Dr. Rachael Guenter shares how her path into neuroendocrine tumor (NET) research began with an early love of math and science, then accelerated through hands-on research experiences in college. She describes studying Phytophthora infestans (the pathogen linked to the Irish potato famine) as a formative training ground for genetics, disease pathology, and core lab techniques—including work with historical DNA to understand how the disease spread in the 1800s. In parallel, she applied chemical engineering knowledge to process control and water purification, building confidence in practical, problem-solving approaches that later carried into biomedical research.Driven by a desire to apply these skills to challenges she felt deeply passionate about, Dr. Guenter pursued a PhD in cancer biology at the University of Alabama at Birmingham (UAB). She explains that she “stumbled into” a lab focused on neuroendocrine cancers—an area she hadn’t known existed at the time—but quickly realized the field was under-researched and urgently needed new insights. Nearly eight years later, she describes NET research as both a continuing scientific puzzle and a powerful motivator: the complexity is high, but so is the impact of every meaningful discovery.A major theme of the interview is translational medicine—moving ideas from bench science toward clinical application. Dr. Guenter emphasizes that this is only possible through close collaboration with clinicians and surgeons who work directly with patients. These partnerships help align laboratory questions with real patient needs (for example, therapies that slow or stop metastasis) and enable access to patient samples through informed consent and surgical collection. She also highlights the reality behind “bench to bedside”: long timelines, extensive safety work, regulatory documentation, and a coordinated team effort.Mass spectrometry is central to her workflow, supporting both mechanistic studies and tumor profiling. Dr. Guenter describes using MS-based approaches to answer fundamental questions—such as identifying proteins involved in gene regulation—and to compare differential protein expression across tumor models, including engineered cell lines tested in vivo. She notes that rare cancers like NETs bring a unique analytical challenge: there is often limited prior literature to interpret results, making the work more pioneering and requiring careful communication and iterative problem-solving. Looking ahead, she is especially excited about spatial mass spectrometry as a way to preserve tumor architecture and heterogeneity—capturing interactions among tumor cells, immune cells, and the microenvironment—to potentially unlock new insights into why some NET subtypes show limited response to immunotherapies.Finally, Dr. Guenter underscores that progress in rare cancers depends on community: scientists, clinicians, and patients working together through open communication and sustained collaboration—often across institutions and borders despite administrative hurdles. She also advocates for broader awareness of neuroendocrine cancer, explaining the “zebra” symbol and the mindset shift it represents: when symptoms are vague and diagnoses can take years, clinicians and the public may need to “think zebras,” not just the most common explanations. She closes on an optimistic note—mass spectrometry and collaborative networks are accelerating discoveries, and she hopes to share more soon as upcoming research is published.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

Unraveling Neuroendocrine Cancer Research with Mass Spectrometry

Article

Academy

Video

Scientists

Interview

Science and research

Laboratories

The University of Amsterdam is one of the largest comprehensive universities in Europe. With some 40,000 students, 6,000 staff, 3,000 PhD candidates, and an annual budget of more than 850 million euros, it is also one of Amsterdam’s biggest employers.

There is an inseparable link between the university and its host city. The freedom and creativity with which Amsterdam has long been associated have worked their way into the fabric of the university. This is a place where individuality, authenticity and diversity are celebrated as sources of stimulation, inspiration and innovation.

Professional and personal development, challenges and collaboration are undertaken in a versatile and multidimensional (inter)national ecosystem with leading stakeholders. Staff at the UvA make a meaningful contribution to uncovering solutions to some of the world’s most significant problems and to developing the next generation of talent.

University of Amsterdam

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

New Food magazine

Agilent Technologies

Technology Networks

Bruker

Phenomenex

SelectScience

SCIEX

Waters Corporation

Reversed-phase high-performance liquid chromatography (RP-HPLC) is a cornerstone technique for peptide analysis due to its exceptional resolving power. In this webinar, we will explore how to optimize RP-HPLC parameters for effective separation of peptides derived from protein digests and analysis of PTMs analysis. Key topics include the role of stationary phase chemistry in influencing selectivity, and how column physical characteristics affect separation performance. We will also examine how mobile phase modifiers—such as trifluoroacetic acid (TFA), formic acid, and pH—impact chromatographic outcomes and compatibility with mass spectrometry (MS). Attendees will gain practical insights into method development strategies that enhance both resolution and detection sensitivity.<blockquote>Presenter: Mohit Patel (Application Engineer, Agilent Technologies, Inc.)Mohit Patel is part of the CSD Online AE Team. His primary focus is to support SMLC, Bio-Columns, and consumables.Before joining Agilent, Mohit was an Assistant Professor of Chemistry at Temple University. Mohit developed his passion for science through his experiences as a faculty researcher and a mentor. Mohit actively taught, developed curriculum, and served as senior personnel, with a leadership position, on funded grants, mentored research projects, and co-coordinator of STEAM related outreach services.Mohit has earned a Doctorate degree in Chemistry from Temple University in 2016.</blockquote>

Agilent Technologies: Advanced RP-HPLC Techniques for Peptide Analysis: From Column Chemistry to Mobile Phase Modifiers

Advanced RP-HPLC Techniques for Peptide Analysis: From Column Chemistry to Mobile Phase Modifiers

We will explore how to optimize RP-HPLC parameters for effective separation of peptides derived from protein digests and analysis of PTMs analysis.

Advanced RP-HPLC Techniques for Peptide Analysis

Discover how modern Listeria monitoring solutions can support faster, more reliable food and environmental testing, and help elevate your laboratory’s efficiency and confidence in results.Listeria remains one of the most challenging pathogens for the food industry due to its ability to persist in production environments and survive under conditions that inhibit many other bacteria, including refrigeration and high-salt processing. Its association with severe illness and food recalls places ongoing pressure on manufacturers and laboratories to detect contamination quickly and reliably across both food and environmental samples.This webinar will explore how Listeria monitoring solutions are evolving to meet these demands, particularly for laboratories balancing speed, cost and operational complexity. Traditional culture methods can delay critical decisions, while PCR and ELISA often require significant capital investment, infrastructure changes and specialist training, creating barriers for low to medium-throughput operations.Using Solus NanoFast™ Listeria as a practical example, the session will demonstrate how alternatives to culture, PCR, and ELISA can support next-day detection through simplified workflows that reduce training requirements and infrastructure changes. The discussion will also highlight how automated result interpretation and digital data management can improve consistency, traceability and audit readiness.<h4>During the session, you will learn how to:</h4><ul><li>Address common challenges in food and environmental Listeria monitoring</li><li>Evaluate cost-effective alternatives to culture, PCR, and ELISA for low to medium-throughput testing (up to ~50 samples/day)</li><li>Improve turnaround times without increasing workflow complexity</li><li>Support audit readiness through objective results and digital traceability</li><li>Align Listeria testing strategies with operational and regulatory requirements</li></ul>Whether you’re overseeing environmental monitoring or finished product testing, this session will deliver practical insights to optimise Listeria testing workflows for efficiency, consistency and confidence in results. Don’t miss this opportunity to streamline your approach to food and environmental Listeria monitoring.<blockquote>Presenter: Nathan Welch, Product Manager at PerkinElmer (Solus)Nathan Welch brings over 25 years of expertise in food safety and quality assurance to the stage. His career spans diverse roles that have shaped his deep understanding of the industry. Starting with two years in a food testing contract laboratory, Nathan advanced into nine years specializing in culture media testing at Oxoid/Thermo Fisher, where he honed his technical and analytical skills.He later transitioned into technical support at Thermo Fisher, providing critical guidance to clients and teams, before moving into product management, a role he has been in for the past 13 years, including nine years at Thermo Fisher and four years at Solus.Presenter: Jean-Paul Anthony, Application Scientist at PerkinElmer (Solus)J-P Anthony is the Applications Scientist for Solus/PerkinElmer contributing to training in the techniques and equipment for food pathogen testing. Prior to this he was a Senior Developmental Scientist and created many aspects of the enzyme and luminescent-based immunoassays including bacterial broth development from the time of the company’s inception in 2009. He trained in Immunology and Pharmacology at the University of Strathclyde before obtaining a PhD in novel drug discovery to combat protozoan parasitical infections at Queen Margaret University, Edinburgh.&nbsp;</blockquote>

New Food Magazine: Rethinking Listeria monitoring: faster, simpler solutions for food safety & environmental testing

Rethinking Listeria monitoring: faster, simpler solutions for food safety & environmental testing

How Listeria monitoring solutions are evolving to meet these demands, particularly for laboratories balancing speed, cost and operational complexity.

Listeria monitoring for food safety & environmental testing

<h4>Designing Robust Metabolomics Studies: From Biological Questions to Analytical Success</h4>Designing a robust metabolomics study requires balancing biological questions with analytical constraints. This webinar guides researchers through the critical decisions that shape successful outcomes - from sample collection and experimental design to choosing targeted or untargeted methods and the right analytical platforms.Attendees will learn practical strategies to minimize bias, enhance data quality, and align methodological choices with study goals. Ideal for scientists seeking clearer pathways through the complexity of metabolomics workflows.<h4>Who should attend?</h4>This webinar is tailored for professionals who want to strengthen their metabolomics study design, including:<ul><li>Academic researchers in biomedical sciences, exposomics, nutrition, and food research</li><li>Pharmaceutical scientists involved in early discovery and translational research</li><li>Anyone seeking practical strategies to reduce bias, improve data quality, and navigate complex metabolomics workflows</li></ul><h4>Key Learning Objectives</h4><ul><li>Understand the core components of metabolomics study design, including biological question definition, cohort selection, and strategies to reduce variability.</li><li>Learn how to choose between targeted, untargeted, and hybrid metabolomics approaches, and know when each method is most appropriate.</li><li>Identify best practices for sample collection, preparation, and QC workflows to ensure high-quality, reproducible data.</li><li>Recognize common pitfalls in metabolomics studies and apply practical strategies to improve robustness, interpretation, and downstream analysis.</li></ul>Ready to elevate your metabolomics research? Register now to secure your spot!<blockquote>Presenter: Dr. Elizabeth Want (Associate Professor in Clinical Mass Spectrometry, Imperial College London)Dr. Elizabeth Want is a Senior Lecturer in the Department of Metabolism, Digestion and Reproduction. She joined Imperial College in 2006 after working as a postdoctoral researcher at the Scripps Research Institute in La Jolla, CA. Prior to that, Elizabeth obtained her PhD in Clinical Biochemistry from King’s College London. At Imperial College, she became a Lecturer in 2007, Senior Lecturer in 2014 and Head of the Section of Bioanalytical Chemistry in 2022. She is also the Director of the Imperial International Phenome Training Centre which runs several hands-on courses in Metabolomics every year.Elizabeth has &gt;25 yrs of experience in mass spectrometry and chromatographic techniques and has spent the past 20 years working in the field of mass spectrometry-based metabolite profiling. Her research focuses primarily on the development and application of novel mass spectrometry (MS) assays for metabolic profiling and on the fusion of mass spectrometric methods with chemometric analysis.Her research at Imperial College has involved the development, optimisation and application of UPLC-MS methodologies for the analysis of biological samples. She applies these methods to biomedical research areas including cardiovascular disease, glioblastoma, neurodegenerative disorders and burn injury.Presenter:&nbsp;David Heywood (Senior Manager Biomedical Research Marketing, Waters Corporation)David has more than 28 years of experience in the mass spectrometry business and has performed many roles - both in the UK and the Americas,including technical hardware and software support, sales, marketing and business development.Now based at Waters’ Mass Spectrometry Head Quarters in Wilmslow UK,David has helped commercialize many of Waters successful high-resolution mass spectrometrybasedsolutions for discovery omics and is now responsible for global marketing strategies of these platforms.</blockquote>

Waters Corporation: Navigating Metabolomics Study Design and Method Choices

Navigating Metabolomics Study Design and Method Choices

Learn how to design robust metabolomics studies—from defining biological questions to selecting targeted or untargeted methods

<div>Discover new perspectives on the complexity of high‑grade serous ovarian cancer in our upcoming webinar, where cutting‑edge spatial multiomics meets real clinical impact. Learn how MALDI Imaging, combined with LMD‑based proteomics, spatial transcriptomics, and MALDI HiPLEX-IHC, is revealing previously unseen cellular subpopulations linked to treatment response and patient survival. This integrated strategy uncovers critical interactions between tumor and microenvironment that may drive chemoresistance and could pave the way for improved patient stratification and more personalized therapy. Join us to explore these groundbreaking results and see how spatial biology is transforming the future of cancer research.<h4>Key Learning Objectives</h4><ul><li>Learn how combining multimodal technologies can accelerate advanced biomarker discovery in oncology research</li><li>Understand how MALDI Imaging adds valuable, untargeted spatial context to existing transcriptomics, proteomics, or imaging workflows</li><li>Identify molecular subtypes and chemoresistance‑related interactions using spatial multiomics</li></ul><h4>Who Should Attend</h4><ul><li>Researchers in oncology, spatial biology, and multiomics</li><li>Clinical and translational scientists seeking new approaches for biomarker discovery and therapy prediction.</li><li>Pharma and biotech professionals developing targeted therapies or exploring tumor–microenvironment interactions.</li><li>Biologists working with transcriptomics, single‑cell, or microscopy methods who want to expand their capabilities into spatial and discover what MALDI Imaging can add</li><li>Anyone interested in cutting‑edge imaging mass spectrometry and its applications in cancer research</li></ul><blockquote>Presenter: Dr. Oliver Klein, Group Leader, Berlin Institute of Health at Charité, Berlin, GermanyDr. Oliver Klein received his master degree in Pharmaceutical/Chemical Engineering at the Beuth University of Applied Sciences and was subsequently focusing on the expression of protein domains to structure elucidation via NMR and mass spectrometry at the Leibniz Institute for Molecular Pharmacology (FMP) Berlin. Since 2007 he is working at the Charité, leading the Proteomics Unit at Berlin-Brandenburg Center for Regenerative Therapies (today BIH Center for Regenerative Therapies) since 2009. 2015 Dr. Klein earned his doctorate in the field of regenerative medicine, focusing on the detection of pathophysiological processes in tissue following cell therapy using Imaging MS and LC MS. From 2022 until today Dr. Oliver Klein leads the “Imaging mass spectrometry Unit at BIH” and is involved in several clinically driven projects including BMBFTR, DFG, EU and industry cooperations.</blockquote></div>

Bruker: Making the Invisible Visible: Unlocking the Potential of Imaging Mass Spectrometry in Ovarian Carcinoma and Beyond

Making the Invisible Visible: Unlocking the Potential of Imaging Mass Spectrometry in Ovarian Carcinoma and Beyond

Spatial multiomics in ovarian cancer showing how MALDI Imaging uncovers tumor heterogeneity, chemoresistance mechanisms, and clinically relevant biomarkers.

Imaging Mass Spectrometry in Ovarian Carcinoma

The microbiology laboratory plays a vital role in selecting antimicrobial susceptibility testing (AST) methods to guide treatment of severe infections in critically ill patients. Delayed or inaccurate results, especially in multi-drug-resistant cases, can lead to poor outcomes and higher mortality.In this SelectScience webinar Dr. James A. McKinnell, M.D. an infectious disease specialist, will describe how accurate minimum inhibitory concentration (MIC) data can improve turnaround times, optimize therapeutic decisions, and support the use of new treatments. The session will explore how reliable broth microdilution-based MICs for novel antibiotics enhance patient outcomes while reducing length of stay, adverse effects, and costs.Join the webinar to learn how antimicrobial stewardship efforts are most effective when supported by timely diagnostics and collaboration among microbiologists, clinicians, stewardship teams, and policymakers, helping to address the global challenge of antibiotic resistance in the post-Covid era.<h4>Key learning objectives:</h4><ul><li>Describe the role of the microbiology laboratory in guiding AST for critically ill patients.</li><li>Recognize the value of accurate MIC data in improving turnaround times, optimizing therapy, and supporting new antibiotic use.</li><li>Identify how antimicrobial stewardship programs rely on timely diagnostic data and collaboration to improve patient outcomes.</li><li>Discuss the importance of multidisciplinary collaboration among microbiologists, clinicians, stewardship teams, and policymakers to combat antibiotic resistance in a post-Covid world.</li></ul><h4>Who should attend?</h4><ul><li>Clinical microbiologists, laboratory technicians, lab managers, lab directors, infectious disease specialists, and infectious disease clinicians.</li></ul><h4>Accreditation statement</h4>SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of these webinars may be entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.<blockquote>Presenter: Dr. James A. McKinnell (M.D. and Infectious Disease Specialist, Milefchik-Rand Medical Group, Torrance and Memorial Medical Center, Torrance CA)Dr. James A. McKinnell is an infectious disease specialist whose research focuses on healthcare-associated infections, particularly VRE, MRSA, and carbapenem-resistant organisms. He has authored over 40 publications on antibiotic optimization and antimicrobial resistance. Dr. McKinnell works closely with skilled nursing facilities in Los Angeles and Orange County (USA) to develop practical infection prevention and stewardship strategies. He also contributes as an invited speaker for the Infectious Disease Association of California and as a committee member for Los Angeles County’s HAI and antimicrobial resistance initiatives.Moderator: Sarah Thomas (Associate Editor, SelectScience)</blockquote>

SelectScience: Critical antimicrobial susceptibility testing results for critical patients: A 2025 perspective

Critical antimicrobial susceptibility testing results for critical patients: A 2025 perspective

Antimicrobial susceptibility testing highlighting role of accurate MIC data in optimizing therapy, stewardship, patient outcomes in critical infections.

Antimicrobial susceptibility testing results

<div>Join the growing community of Andrew+ laboratory automation users and discover real research, practical insights, and peer‑to‑peer knowledge sharing.<h4>WHAT WILL YOU LEARN</h4><ul><li>Real-world case studies from academic labs using Andrew+ today</li><li>Best-practice approaches shared directly by experienced users</li><li>Tips for integrating Andrew+ into your sample preparation workflows</li><li>Ways to automate tasks to increase efficiency and reduce variability</li><li>Opportunities to connect with peers facing similar research challenges</li></ul><h4>WHO SHOULD ATTEND</h4><ul><li>Academic researchers using or evaluating Andrew+</li><li>Lab members involved in sample preparation or workflow optimization</li><li>Anyone looking to introduce automation into their daily lab activities</li></ul>REGISTER NOW!This event offers a unique chance to hear directly from the academic user community and discover practical insights that you can immediately apply in your own lab.You’ll leave with new ideas, shared experiences, and a clearer understanding of how Andrew+ can support and streamline your research.<blockquote>Presenter: Alex Dickens, Turku UniversityPresenter: Otto Kauko, Turku UniversityPresenter: Samira Salihovic, Örebro UniversityChairman: Paul Heads, Nordics Automation Specialist - Waters</blockquote></div>

Waters Corporation: Nordics Lab Automation Online Users Meeting

Nordics Lab Automation Online Users Meeting

Join the growing community of Andrew+ laboratory automation users and discover real research, practical insights, and peer‑to‑peer knowledge sharing.

Join us for an in-depth webinar on a robust and ultra-fast method for the analysis of trifluoroacetic acid (TFA) in multiple water sources using the SCIEX 7500+ system, together with a Phenomenex Luna Omega column, enabling high-throughput workflows with minimal sample handling. The method, which includes confirmation with both a quantifier and qualifier transition for confirmation, achieves a rapid turnaround time of just 4 minutes and 30 seconds between samples, allowing for the processing of 40 samples—including blanks and standards—in under four hours.<h4>What to expect:</h4><ul><li>Deep understanding of TFA’s environmental relevance</li><li>Skills to run validated LC–MS/MS methods for TFA</li><li>Knowledge of instrument setup and troubleshooting</li><li>Experience with calibration, quantification, and QC</li><li>Best practices for sample handling, data interpretation, and reporting</li><li>Awareness of regulatory frameworks driving TFA monitoring</li></ul><h4>Key learning points:</h4><ul><li>Highly sensitive and robust analytical method for TFA analysis in water samples</li><li>Fast, high‑throughput workflow</li><li>How to address TFA contaminations</li><li>Excellent robustness across long sequences</li><li>Reliable performance across complex water matrices</li><li>Regulatory context highlights growing importance of TFA monitoring</li></ul><h4>Who should attend:</h4><ul><li>Environmental chemists</li><li>Water‑quality laboratories</li><li>LC‑MS/MS analysts and technicians</li><li>Regulatory and compliance professionals</li><li>PFAS researchers</li><li>Industrial chemists (chemical, agrochemical, materials)</li><li>Technical marketing and application specialists</li></ul>We will send you the recording after the event.<blockquote>Speaker: Carlos Bueno, Senior Application Support SpecialistCarlos finished his Bachelor Degree in Chemistry in 2001. Before starting working as applications specialist he worked 4 years in Madrid doping control laboratory. Working in SCIEX since 2023 as Senior Application Support Specialist for EMEA. More than 20 years of experience in Chromatography and Mass spectrometry mostly focused on the development of application in food and environmental markets.</blockquote>

SCIEX: A fast and ultra-sensitive method for analysis of TFA in multiple water sources

A fast and ultra-sensitive method for analysis of TFA in multiple water sources

Webinar on ultra-fast LC-MS/MS analysis of TFA in water with SCIEX 7500+, covering validation, QC, and regulatory drivers.

Ultra-sensitive method for analysis of TFA in water sources

<div>As biopharmaceutical manufacturers move toward continuous bioprocessing, downstream purification must evolve to keep pace with demands for efficiency, flexibility, and scalability. Multi-column chromatography is central to this shift, yet implementation challenges around consistency, changeover, and operational readiness remain.This webinar examines how advances in column design are helping teams overcome these barriers and accelerate adoption of continuous and semi-continuous purification strategies.Through real-world examples, attendees will gain insight into practical approaches that support robust processes, streamlined facilities, and faster deployment while advancing industry efforts to expand patient access to critical therapies.<h4>Attend this webinar to:</h4><ul><li>Understand the industry drivers accelerating the transition from batch to continuous bioprocessing</li><li>Explore the role of multi-column chromatography in integrated continuous manufacturing</li><li>Learn how pre-packed chromatography columns enable consistency, flexibility, and rapid implementation</li><li>Identify practical considerations for adopting pre-packed columns in continuous downstream operations</li></ul><blockquote>Presenter: Adam Nelson (Senior Product Manager at Repligen Corporation)Adam Nelson has 16 years of experience in pre-packed chromatography column manufacturing and product development. In his current role, as product manager for OPUS, large scale pre-packed chromatography columns, he is responsible for new product development, product line extensions and product innovation. In prior roles, Adam developed packing protocols that enable OPUS pre-packed chromatography column packing technology. Additionally, Adam led the team responsible for materials management, process control, and process development for OPUS large scale chromatography column manufacturing. He has a passion for customer service and leveraging his technical expertise to deliver an optimal customer experience. Adam holds a bachelor's in chemical engineering from the University of Massachusetts Amherst and a graduate's certificate in innovation management from Northeastern University.</blockquote></div>

Technology Networks: Enabling Continuous Bioprocessing With Multi-Column Chromatography

Enabling Continuous Bioprocessing With Multi-Column Chromatography

Webinar on multi-column chromatography and pre-packed columns for efficient, scalable continuous bioprocessing.

Continuous Bioprocessing With Multi-Column Chromatography

Join our upcoming webinar on extractables and leachables and explore the complete extractables and leachables workflow using the SCIEX X500R QTOF system. Learn how to achieve precise screening, confident quantitation, and streamlined data interpretation with SCIEX OS software. The session will also cover best practices and practical considerations for implementing robust extractables and leachables workflows in regulated environments.<h4>Key highlights:</h4><ul><li>Overview of extractables and leachables</li><li>Precision screening and quantitation with the SCIEX X500R QTOF system</li><li>Streamlined acquisition and data interpretation using SCIEX OS software</li></ul><blockquote>Speaker: Kiran Maan, Application Support Scientist</blockquote>

SCIEX: Extractables and leachables: the complete workflow using the SCIEX X500R QTOF system

Extractables and leachables: the complete workflow using the SCIEX X500R QTOF system

Explore the complete extractables and leachables workflow using the SCIEX X500R QTOF system.

Extractables and leachables workflow using SCIEX X500R QTOF

<h4>Key Learning Points</h4><ul><li>Understand why GLP-1 analogues are difficult to purify (structural similarity, truncations, aggregates).</li><li>Learn how to design purification strategies using a single stationary phase.</li><li>Understand regulatory and CMC implications when scaling peptide purification processes.</li></ul><h4>Who Should Attend</h4><ul><li>Any scientists, industry leaders, and researchers driving the future of peptide purification and GLP‑1 therapeutics.</li></ul><blockquote>Speaker: Dhanunjaya Naidu (Business Development Manager, Phenomenex)Dhanunjaya Naidu has earned a master’s degree in Organic Chemistry from Andhra University, India and brings 19 years of experience in synthesis, analytical method development and Purifications. In the past 7 years at Phenomenex, he has given many technical presentations, Analytical method development support, Column positioning and troubleshooting assistance. Currently, he is working as a Business Development Manager at Phenomenex India, and responsible for Pan India Purification Technologies Products. He has publications in reputed international journals in organic synthesis.</blockquote>

Phenomenex: Purification Strategies for GLP-1 Analogues: Two-Step RP-LC Method Development with Case Studies

Purification Strategies for GLP-1 Analogues: Two-Step RP-LC Method Development with Case Studies

Webinar on GLP-1 peptide purification—strategy design, impurity control, and regulatory/CMC insights for scalable processes.

Related content

Unraveling Neuroendocrine Cancer Research with Mass Spectrometry

Advanced equipment for self-driving analytical AI laboratory

Alternatives to Traditional Fume Hoods: A Comprehensive Guide to Laboratory Containment Solutions